No skullduggery involved in pharma equiry submission switch says EPO

On Monday, the IP Kat blog ran a worrying story about apparent changes to the European Patent Office's submission to the DG Compeition's on-going enquiry into the pharmaceutical sector. IP Kat co-author Jeremy Phillips, who many of you will…

Get unlimited access to all IAM content